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strongly expressed in mesangial cells in active IgAN accompa-Mesangial factor V expression colocalized with fibrin deposi-
nied with mesangial proliferation and may exert procoagulanttion in IgA nephropathy.
activity, leading to intramesangial coagulation.Background. Factor V in its active form (Va) plays a key
role at the termination of the intrinsic coagulation pathway,
serving as a membrane-bound cofactor for the conversion of
prothrombin to thrombin by factor Xa. Cross-linked fibrin
Coagulation is an important event in the development(XFb) is often observed in mesangial areas in active types of
of severe mesangioproliferative or crescentic glomerulo-human glomerulonephritis. In this study, to clarify contribution
of factor V in intramesangial coagulation, mesangial factor V nephritis. We have reported that the intact form of cross-
expression and its relationship to mesangial proliferation and linked fibrin (XFb) is often observed in mesangial areas
fibrin deposition in IgA nephropathy (IgAN) were investigated. in active mesangioproliferative glomerulonephritis usingMethods. Twenty-two patients with IgAN were studied.
the monoclonal antibody DD3B6/22 against d-dimer,XFb was detected in renal biopsy specimens using anti–d-dimer
combined with plasmin exposure [1, 2]. The intact formantibody combined with plasmin exposure, and factor V was
detected with rabbit antibody against human factor V. Double- of XFb suggests that it is newly produced in the mesan-
labeling immunohistochemistry was used to investigate the re- gial areas and that intramesangial coagulation proceeds
lationship of the glomerular distribution of factor V to XFb. in accordance with mesangial proliferation. In vivo, mes-The relationship of factor V staining to the activity index or
angial cells are supplied with various coagulation factorsXFb deposition was evaluated. The expression of factor V
from blood circulation through fenestration of capillarymRNA was assessed by in situ hybridization in relationship to
the antigen staining of a-smooth muscle actin (a-SMA). The endothelium [3]. In physiological states, fibrin deposition
ultrastructural distribution of factor V in glomeruli was studied is scarcely observed in glomeruli. After inflammatory
by immunoelectron microscopy.
change, inactive forms of coagulation factors are con-Results. XFb and factor V were observed in the mesangium
verted to active forms, and finally, XFb may be producedand along capillary loops in seven and nine specimens, respec-
tively. Factor V had intense, frequent expression in the prolifer- in mesangial areas. Out of the various coagulation fac-
ating and necrotizing areas, showing a significant relationship tors, tissue factor is known to be the initiator in the
to XFb (P , 0.05). Furthermore, XFb deposition and factor extrinsic coagulation cascade, the major cascade in theV expression were markedly correlated with disease activity
inflammatory diseases, and thereafter, to convert factor(P 5 0.005 and P 5 0.008, respectively). By double-labeling
X to active form Xa. On the other hand, factor V in itsexperiments, XFb and factor V were often seen colocalized in
mesangial areas of the glomeruli, which showed necrotizing active form (Va) serves as a membrane-bound cofactor
lesions and/or intense cellular proliferation. By in situ hybrid- to factor Xa, which facilitates activation of prothrombin
ization, factor V mRNA was detected mainly in the mesangial
to thrombin. Then thrombin immediately converts fi-cells, which were positive for a-SMA, and partly in the endothe-
brinogen to fibrin. It is known that the rate of prothrom-lial cells. By immunoelectron microscopy, factor V presence
was confirmed in the mesangium and endothelium. bin activation by the prothrombinase complex, Xa/Va,
Conclusion. The present findings suggest that factor V is is about 300,000 times higher than the rate of activation
by factor Xa alone [4, 5]. Thus, factor Va plays a key
role nearly in the ending of the coagulation pathway. AsKey words: glomerulonephritis, renal biopsy, cross-linked fibrin, in-
flammatory response, a-smooth muscle actin. factor V is known to be expressed in various circulating
and noncirculating cells such as platelets [6, 7], endothe-Received for publication June 29, 1999
lial cells [8], monocytes [9], and hepatocytes [10], theand in revised form February 4, 2000
Accepted for publication March 10, 2000 expression of this factor in renal parenchymal cells, in-
cluding mesangial cell, is highly suspected and plays aÓ 2000 by the International Society of Nephrology
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crucial role in local coagulation in various mesangium- then developed by incubation with fast red dye (Dako).
The sections were counterstained with hematoxylin.involving glomerulonephritis, especially in IgA nephrop-
Factor V was detected by an indirect method using aathy (IgAN). In this study, we studied the mesangial
monospecific rabbit antibody against human factor V,factor V expression in relationship to XFb deposition
RAHu/FV (Nordic Immunological Laboratories, Tilbung,and disease activity in IgAN.
Netherlands), as described previously [12]. Briefly, the
sections were incubated with antibody RAHu/FV fol-
METHODS lowed by biotinylated antirabbit IgG (Vector Labora-
Patients tories, Burlingame, CA, USA). The sections were then
reacted with avidin-DH-biotinylated horseradish peroxi-Three patients with minor glomerular abnormalities
dase complex (Vectastain ABC kit; Vector Labora-and 22 patients with IgAN were studied. The glomerular
tories). Color was then developed by incubation withlesions of mesangial cell proliferation, necrotizing lesion,
an ImmunoPure Metal Enhanced DAB Substrate kitcellular crescent formation, and mononuclear interstitial
(Pierce, Rockford, IL, USA). Positivity of XFb and fac-infiltrate were scored to determine the activity index (AI)
tor V was scored in a range of 0 to 3, with 0 indicatingaccording to the modified criteria of Austin et al [11],
absence, 1 indicating less than 25% of glomerular tufts,which was originally developed for systemic lupus ery-
2 indicating 25 to 50%, and 3 indicating more than 50%.thematosus (SLE), except for wire loops and leukocyte
Proliferating cell nuclear antigen (PCNA) was de-infiltrate in glomeruli. The presence of mesangial cell
tected on sections that were Doubosque-Brazil fixed,proliferation and interstitial mononuclear infiltrate was
paraffin embedded, cut into 4 mm, and deparaffinizedscored in a range of 0 to 3, with 0 indicating absence, 1
using mouse monoclonal antibody against proliferatingindicating mild (less than 30% of all glomeruli involved,
cell nuclear antigen (EPOS; Dako). Color was then de-or focal interstitial infiltrate), 2 indicating moderate
veloped by incubation with a DAB Substrate kit (Pierce).(30% to 70% of all glomeruli involved or multiple foci
of interstitial infiltrate), and 3 indicating severe (more Double-labeling experiment
than 70% of all glomeruli involved or diffuse interstitial
Fresh frozen tissue sections were fixed in acetone andinfiltrate). The presence of necrotizing lesion and cellular
stained indirectly according to a modified method pre-crescent was scored in a range of 0 to 3, with 0 indicating
viously reported [13]. After incubation with plasmin, theabsence, 1 indicating less than 10% of the glomeruli
sites of antigen-antibody reaction were revealed by incu-
involved, 2 indicating 10 to 30%, and 3 indicating more
bating each section with rabbit antibody against human
than 30%. Scores of necrotizing lesion and cellular cres- factor V, RAHu/FV, followed by biotinylated antirabbit
cent were each multiplied by 2, according to the original IgG. The preparations were washed twice in Tris-buf-
criteria. The maximal AI was 18. The diagnoses were fered saline (pH 7.4) and incubated with the monoclonal
confirmed by renal biopsy by light microscopy, immuno- antibody DD3B6/22, rabbit anti-mouse immunoglobu-
fluorescence microscopy, and electron microscopy, in ad- lins (Dako), and mouse APAAP complex (Dako). Color
dition to clinical findings. was then developed by incubation with fast red dye
(Dako) and DAB Substrate kit (Pierce).Immunoperoxidase staining for XFb, factor V, and
proliferating cell nuclear antigen In situ factor V mRNA hybridization
Biopsy specimens were frozen in OCT compound In situ hybridization was performed according to a
(Miles Laboratories, Elkhart, IN, USA), cut into serial modified method previously reported [14]. Briefly, 30-
sections on a cryostat, fixed in acetone for five minutes mer oligonucleotide probes, which corresponded to the
at room temperature, and stained indirectly. XFb was antisense (59-TGC ATC CCA GCT TGC AAA TGT
detected indirectly before and after plasmin exposure TTT GGG GTG-39) and sense (59-CAC CCC AAA
using the monoclonal antibody specific for d-dimer, ACA TTT GCA AGC TGG GAT GCA-39) of human
DD3B6/22 (AGEN, Brisbane, Australia). The method of factor V cDNA [5], labeled with a Digoxigenin Oligonu-
plasmin treatment was described previously [1]. Briefly, cleotide Tailing kit (Boehringer Mannheim Biochemica,
sections were treated with the active form of plasmin Mannheim, Germany), were used. The fresh frozen tis-
(Nacalai Tesque, Kyoto, Japan) for 20 minutes at room sue sections were fixed in ice-cold 4% paraformaldehyde
temperature at a concentration of 0.25 U/mL in 0.01 for 15 minutes. Sections were prehybridized for 1.5 hours
mol/L phosphate-buffered saline (pH 7.4). The prepara- at 378C in prehybridization solution and 200 mg/mL soni-
tions were washed in Tris-buffered saline (pH 7.4) and cated denatured herring sperm DNA (Sigma, St. Louis,
incubated with antibody DD3B6/22 for one hour, rabbit MO, USA). Hybridization was carried out at 378C over-
anti-mouse immunoglobulins (Dako, Glostrup, Den- night with either sense or antisense probes. Sections were
washed in 2 3 standard saline citrate (SSC), 1 3 SSC,mark), and mouse APAAP complex (Dako). Color was
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Table 1. Clinical and laboratory data in patients with IgAN0.5 3 SSC, and finally washed in 0.1 3 SSC. Immunologi-
cal detection of the hybridized probes was performed Urinary Urinary RBCa Serum
Patient Age Male/ protein N/HPF b of creatininewith monoclonal anti-DIG, rabbit anti-mouse immuno-
no. years female g/day sediment mg/dLglobulins (Dako), and mouse APAAP complex (Dako).
1 23 F 0.1 25 0.4Color was then developed by incubation with fast red
2 21 M 0.0 6 0.9
dye (Dako). Finally, sections were counterstained with 3 23 M 0.0 10 0.8
4 24 F 0.1 65 0.5hematoxylin.
5 25 M 0.3 3 0.7
6 21 F 0.0 30 0.7Simultaneous in situ detection of factor V mRNA and
7 28 F 0.7 50 0.7
antigen immunostaining of a-smooth muscle actin 8 21 F 1.8 7 0.6
9 55 F 0.0 13 0.8To confirm the synthesis of factor V by mesangial
10 33 F 0.2 8 0.6
cells, simultaneous in situ hybridization for factor V and 11 45 F 1.0 4 0.6
12 40 M 0.4 35 1.0antigen labeling for a-smooth muscle actin (a-SMA) was
13 20 F 0.2 40 0.7performed according to a modification of the method
14 27 F 0.3 25 0.7
previously reported [15]. Fresh frozen tissue sections 15 25 F 0.6 100 0.7
16 22 F 0.6 40 0.6were fixed, incubated with the monoclonal antihuman
17 21 M 1.1 25 0.9a-SMA (Dako) for one hour, and followed by biotinyl-
18 15 M 0.3 25 0.7
ated anti-mouse IgG (Vector Laboratories). The sections 19 14 M 2.3 80 0.8
20 22 M 0.6 15 1.0were then reacted with avidin-DH-biotinylated horse-
21 26 F 0.1 25 0.7radish peroxidase complex (Vector Laboratories), and
22 51 M 1.1 35 1.2
color was then developed by incubation with the DAB Mean M59
6SD 27610 0.560.6 30625 0.760.2Substrate kit (Pierce). Slides were washed twice in dis- F513
tilled water and prepared for in situ hybridization by
treatment with 0.2 N HCl for 10 minutes to remove aRBC, red blood cell
bHPF, high-power fieldimmunoglobulins. Hybridization was carried out with
either sense or antisense human factor V cDNA probes,
and hybridized probes were detected as described pre-
viously in this article.
compared according to the histologic parameters of dis-
ease activity. Factor V expression was also correlated withImmunoelectron microscopy
XFb deposition. The values were reported as mean 6 SD,Part of the biopsy specimen was fixed in periodate-
and P , 0.05 was regarded as significant.lysine-paraformaldehyde according to the method of
McLean and Nakane [16]. After washing with different
concentrations of sucrose solutions (10, 15, and 20%), the RESULTS
specimen was frozen in OCT compound and sectioned
Table 1 summarizes the clinical and laboratory data(6 mm) on a cryostat [17]. These sections were etched by
of IgAN patients. The distribution of disease activity0.3% hydrogen peroxide for 15 minutes. After washing
presented two groups of inactive IgAN (AI 1 to 4; pa-with phosphate-buffered saline (PBS), the sections were
tients 1 through 11), and active IgAN (AI 7 to 15; patientstreated with 10% normal goat serum, followed by incu-
12 through 22), lacking AI 5 or 6 cases. Each groupbation with rabbit antibody against human factor V,
consisted of 11 cases, as shown in Table 2. Figure 1ARAHu/FV, at 48C overnight. After washing, further incu-
shows microscopic findings in an inactive IgAN (AI 2)bation followed with biotinylated antirabbit IgG for
with slight mesangial widening. In an active IgAN casethree hours. The sections were then reacted with avidin-
(AI 13), moderate diffuse mesangial proliferation wasDH-biotinylated horseradish peroxidase complex (Vec-
observed, as shown in Figure 1B. To determine the pro-tor Laboratories) for three hours, and color was devel-
liferation of glomerular cells, tissue sections were immu-oped as described previously in this article. Sections were
nostained for PCNA. Figure 1C shows PCNA stainingpostfixed in 2% osmic acid and embedded in Epon 812
in an inactive IgAN, and Figure 1D shows PCNA staining(Oken Shoji), and ultrathin sections were cut. Observa-
in an active case. The number of PCNA-positive cells intion was performed with a Hitachi 7100 electron micro-
glomeruli from active cases of IgAN (mean 6 SD 5scope (Tokyo, Japan).
2.8 6 1.2) was approximately ninefold greater than that
Statistics from inactive cases (0.3 6 0.4).
XFb staining was all negative in the three specimensStatistical analysis was performed using the x2 test and
from minor glomerular abnormalities. In IgAN, afteranalysis of correlation. The XFb staining after plasmin
exposure and the positivity of factor V staining were plasmin treatment, XFb immunoreactivity turned posi-
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Fig. 1. Mesangial proliferation both in inac-
tive and in active IgA nephropathy (IgAN).
Mesangial proliferation is slightly observed in
a glomerulus in inactive type (A) and moder-
ately detected in active type (B). With an anti-
body against PCNA, several proliferating cells
in the mesangium (arrows) are detected by
immunostaining in a glomerulus with active
IgAN (D), while no positive cells are observed
in a glomerulus with inactive IgAN (C; final
magnification, 3210).
tive in 6 of 21 renal biopsy specimens except one case, in staining after plasmin exposure resembled the distribu-
tion of factor V staining. The double-immunolabelingwhich XFb staining was already positive before plasmin
immunohistochemistry to the same glomerulus with Fig-treatment. The positivity of XFb after plasmin exposure
ures 2D and 3B revealed the colocalization of XFb andwas 7 out of 22 (32%) of total cases, 1 out of 11 (9%)
factor V in proliferating and necrotic lesions (Fig. 4).of inactive cases, and 6 out of 11 (55%) of active cases.
Expression of factor V mRNA was detected in theXFb staining was negative before and after plasmin ex-
regions of cell proliferation in the specimen from patientposure in inactive IgAN (Fig. 2 A and B). Positive XFb
21 using the antisense probe (Fig. 5B), whereas the nega-staining was observed mainly in proliferating and/or nec-
tive control with the sense probe resulted in no stainingrotizing lesions, especially after plasmin exposure. As
in any of these regions (Fig. 5A). This distribution wasshown in Figure 2 C and D, positive staining was detected
similar to that of the cell expressing factor V proteins.diffusely in the mesangium and segmentally in capillary
Furthermore, simultaneous immunohistochemistry forloops in the same specimen with Figure 1D.
a-SMA and in situ hybridization for factor V mRNAFactor V staining was negative in all specimens from
expression was performed in an active IgAN patient 14,minor glomerular abnormalities. In the inactive IgAN,
as shown in Figure 5 C and D. a-SMA immunostainingsfactor V staining was negative (Fig. 3A) except for two
were discrete and localized to mesangial cells in the glo-cases. In an active case, factor V staining was detected
merulus. In the mesangium, a-SMA antigen-positivein mesangial cells and along capillary loops, and its ex-
cells also showed factor V mRNA expression, althoughpression was intense and frequent in the proliferating
there were other a-SMA–negative cells that were posi-and/or necrotizing areas (Fig. 3B) in the same specimen
tive for factor V mRNA observed along capillary walls.with Figure 1D. Factor V staining was detected in 9 of
However, no hybridization with the sense probe was ob-the total 22 (41%), showing a significant relationship
served after a-SMA antigen staining (results not shown).
with that of XFb after plasmin exposure (P 5 0.02). As By immunoelectron microscopy, factor V presence
shown in Table 2, XFb deposition and factor V expres- was confirmed in the cytoplasm of both mesangial cells
sion presented a significant correlation with mesangial and endothelial cells in a glomerulus from an active
cell proliferation, necrotizing lesion, cellular crescents IgAN (Fig. 6).
formation, and PCNA-positive cells per glomerulus, es-
pecially with AI (P 5 0.005 and P 5 0.008, respectively).
DISCUSSIONFactors V and XFb were often colocalized in glomeruli
of highly active type IgAN, as shown in Figures 2D and Intraglomerular coagulation is thought to be involved
in the development of glomerular injury [18, 19]. Various3B of the same glomerulus from patient 12. Intense XFb
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Fig. 2. Cross-linked fibrin (XFb) before and
after plasmin exposure both in inactive and
in active IgAN. Staining for XFb is negative
in the glomerulus in inactive type before (A)
and after (B) plasmin exposure. Staining for
XFb is negative before plasmin exposure (C),
but positive after plasmin exposure, both in
the mesangium (arrowheads) and along capil-
lary loops (arrow; D) in active type (final mag-
nification, 3210).
Fig. 3. Factor V immunostaining both in in-
active and in active IgAN. Factor V is negative
in inactive IgAN (A), and positive intensely
in the mesangium (arrowheads), and weakly
along capillary loops (arrow), in active IgAN
(B; final magnification, 3210).
coagulation factors have been previously observed in the tion, which may lead to glomerular sclerosis. The liver
and megakaryocytes are known to synthesize factor Vglomeruli of renal biopsy specimens by our group and
other authors [17, 20–23]. In the recent study by Cun- [26]. It is converted to its active cofactor, Va, from factor
V by thrombin or factor Xa [27]. The Xa/Va complex,ningham et al, tissue factor pathway inhibitor is shown
to be dysregulated in the early stages of human crescentic which is formed on membranes, is known as the pro-
thrombinase complex, since it serves to convert pro-glomerulonephritis when there is significant fibrin depo-
sition [24]. thrombin to thrombin. Subsequently, thrombin converts
fibrinogen to fibrin [28].In IgAN, the major abnormality is mesangial prolifera-
tive glomerulonephritis accompanied by sclerosis and oc- Therefore, in this study, we examined the mesangial
expression of factor V in relationship to intact XFb depo-casionally necrosis and crescents [25]. In our previous study,
we observed an increase in immunoreactivity after plas- sition in the mesangium and level of disease activity. To
determine the source of factor V and the mechanisms ofmin exposure using the monoclonal antibody DD3B6/22,
in renal biopsy specimens from both IgAN and Henoch- XFb production in the glomeruli, we performed four ex-
periments: (1) immunohistochemistry for factor V, XFb,Scho¨nlein purpura nephritis, which showed the presence
of intact XFb in glomeruli. We presented our hypothesis and PCNA on biopsy sections; (2) double staining for
factor V and XFb to determine their colocalization; (3)that the intact XFb in the mesangium may be related to
mesangial cell proliferation [2]. As for factor V expres- in situ hybridization for factor V mRNA in the mesangial
cells in relationship to a-SMA antigen expression; (4)sion, it is important to promote intraglomerular coagula-
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Fig. 4. Double immunostaining of the glo-
merulus for XFb and factor V in the same
glomerulus as shown in Figures 2D and 3B. In
the areas of the mesangial cell proliferations,
XFb (red, arrows) and factor V (dark brown,
arrowheads) are colocalized. The boxed area
in A is shown at a higher power in B (final
magnification, A 3210; B 3800).
Fig. 5. Expression of factor V mRNA in the
glomerulus from an active IgAN case. The sec-
tions are hybridized with either sense (A) or
antisense (B) factor V probes using serial sec-
tions. Localization of factor V mRNA (arrows,
red) in a glomerulus shows expression of the
factor V gene. Simultaneous in situ detection
of factor V mRNA (red) and immunostaining
for antigen of a-SMA (darkbrown) shows col-
ocalization in mesangial cells (C). The boxed
area is shown at a higher power in D (final
magnification, A, B, and D 3490; C 3210).
Fig. 6. Ultrastructural distribution of factor
V viewed by immunoelectron microscopy in
a glomerulus from the same case as Figure
4. Factor V is observed in both a mesangial
(arrows) and an endothelial cell (arrowheads;
final magnification, 315,400).
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segmentally along capillary loops. Factor V was also
expressed in these regions. Furthermore, the deposition APPENDIX
of factor V and the expression of factor V correlated
Abbreviations used in this article are: AI, activity index; a-SMA,markedly with the degree of disease activity. Based on alpha-smooth muscle actin; factor Va, factor V in its active form; IgAN,
the findings of these experiments, it is suggested that IgA nephropathy; PCNA, proliferating cell nuclear antigen; SLE, sys-
temic lupus erythrematosus; XFb, cross-linked fibrin.XFb production is promoted through factor V up-regula-
tion in mesangial cells in active-type IgAN. In this con-
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